Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene

Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the dystrophin gene that ablate functional protein expression. Although exonic deletions are the most common Duchenne muscular dystrophy lesion, duplications account for 10-15% of reported disease-causing mutations...

Full description

Saved in:
Bibliographic Details
Main Authors: Kane L Greer (Author), Hanns Lochmüller (Author), Kevin Flanigan (Author), Susan Fletcher (Author), Steve D Wilton (Author)
Format: Book
Published: Elsevier, 2014-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4851980feaf64c7490bb8f380cf6e7f5
042 |a dc 
100 1 0 |a Kane L Greer  |e author 
700 1 0 |a Hanns Lochmüller  |e author 
700 1 0 |a Kevin Flanigan  |e author 
700 1 0 |a Susan Fletcher  |e author 
700 1 0 |a Steve D Wilton  |e author 
245 0 0 |a Targeted Exon Skipping to Correct Exon Duplications in the Dystrophin Gene 
260 |b Elsevier,   |c 2014-01-01T00:00:00Z. 
500 |a 2162-2531 
500 |a 10.1038/mtna.2014.8 
520 |a Duchenne muscular dystrophy is a severe muscle-wasting disease caused by mutations in the dystrophin gene that ablate functional protein expression. Although exonic deletions are the most common Duchenne muscular dystrophy lesion, duplications account for 10-15% of reported disease-causing mutations, and exon 2 is the most commonly duplicated exon. Here, we describe the in vitro evaluation of phosphorodiamidate morpholino oligomers coupled to a cell-penetrating peptide and 2'-O-methyl phosphorothioate oligonucleotides, using three distinct strategies to reframe the dystrophin transcript in patient cells carrying an exon 2 duplication. Differences in exon-skipping efficiencies in vitro were observed between oligomer analogues of the same sequence, with the phosphorodiamidate morpholino oligomer coupled to a cell-penetrating peptide proving the most effective. Differences in exon 2 excision efficiency between normal and exon 2 duplication cells, were apparent, indicating that exon context influences oligomer-induced splice switching. Skipping of a single copy of exon 2 was induced in the cells carrying an exon 2 duplication, the simplest strategy to restore the reading frame and generate a normal dystrophin transcript. In contrast, multiexon skipping of exons 2-7 to generate a Becker muscular dystrophy-like dystrophin transcript was more challenging and could only be induced efficiently with the phosphorodiamidate morpholino oligomer chemistry. 
546 |a EN 
690 |a antisense oligomers 
690 |a Duchenne muscular dystrophy 
690 |a duplication mutations 
690 |a dystrophin 
690 |a exon skipping 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Molecular Therapy: Nucleic Acids, Vol 3, Iss C (2014) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S2162253116302955 
787 0 |n https://doaj.org/toc/2162-2531 
856 4 1 |u https://doaj.org/article/4851980feaf64c7490bb8f380cf6e7f5  |z Connect to this object online.